| # | Drug | Count |
|---|---|---|
| 0 | ATENOLOL | 3 |
| 1 | BISOPROLOL FUMARATE | 3 |
| 2 | NIRAPARIB | 3 |
| 3 | ADALIMUMAB | 2 |
| 4 | APIXABAN | 2 |
| 5 | ASPIRIN | 2 |
| 6 | ASPIRIN 325 MG | 2 |
| 7 | ASPIRIN 81 MG | 2 |
| 8 | CYCLOBENZAPRINE | 2 |
| 9 | CYCLOPHOSPHAMIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PYRIMETHAMINE | 1 | 0.0008 |
| 1 | IDARUCIZUMAB | 1 | 0.0007 |
| 2 | PACRITINIB | 1 | 0.0003 |
| 3 | MARC GLASSMAN | 1 | 0.0003 |
| 4 | DOCUSATE SODIUM AND SENNOSIDES | 1 | 0.0002 |
| 5 | DOCUSATE CALCIUM | 1 | 0.0002 |
| 6 | DOCUSATE SODIUM SENNOSIDES | 1 | 0.0002 |
| 7 | TAMOXIFEN CITRATE | 1 | 0.0002 |
| 8 | TOPOTECAN | 1 | 0.0002 |
| 9 | NIRAPARIB | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 1 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 2 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 3 | Cardiac Glycoside [EPC] | 2 | 0.0000 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 5 | Interleukin-23 Antagonist [EPC] | 2 | 0.0000 |
| 6 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Methylxanthine [EPC] | 1 | 0.0000 |
| 8 | Angiotensin Converting Enzyme Inhibitor [EPC] | 2 | 0.0000 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |